Raymond James Financial Services Advisors, Inc. Zomedica Corp. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$0.2 - $0.38 $3,183 - $6,047	15,915 New	15,915 $3,000
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.34 $7,623 - $12,959	-38,115 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$0.28 - $0.4 $3,920 - $5,600	14,000 Added 58.06%	38,115 $13,000
Q4 2021 Feb 08, 2022	SELL	$0.31 - $0.58 $1,209 - $2,262	-3,900 Reduced 13.92%	24,115 $7,000
Q3 2021 Nov 02, 2021	SELL	$0.46 - $0.81 $16 - $28	-35 Reduced 0.12%	28,015 $15,000
Q2 2021 Aug 11, 2021	BUY	$0.72 - $1.46 $2,372 - $4,810	3,295 Added 13.31%	28,050 $23,000
Q1 2021 May 14, 2021	BUY	$0.35 - $2.7 $8,664 - $66,838	24,755 New	24,755 $39,000

Others Institutions Holding ZOM

# of Institutions

Shares Held

80.9M

Call Options Held

Put Options Held

View Full List

About Zomedica Corp.

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

More about ZOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account